James R. Engle

Director Técnico/Científico/I+D en Talecris Biotherapeutics Holdings Corp. .

68 años

Health Technology

Consumer Services

Cargos activos de James R. Engle

Empresas	Cargo	Inicio	Fin
Talecris Biotherapeutics Holdings Corp. Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC.	Director Técnico/Científico/I+D	24/03/2010	-
	Corporate Officer/Principal	24/03/2010	24/03/2010

Empresas	Cargo	Inicio	Fin
Aventis, Inc.	Director Técnico/Científico/I+D	01/01/2004	01/01/2004
CSL Behring LLC CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA.	Director Técnico/Científico/I+D	-	-

Delaware Valley University

Undergraduate Degree

Internacional

Estados Unidos

Operativa

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	1
Undergraduate Degree	1

Sectorial

Health Technology	3
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	3
Talecris Biotherapeutics Holdings Corp. Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC.	Health Technology
Aventis, Inc.
CSL Behring LLC CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA.	Health Technology